Patents/Assignees

Dyne Therapeutics, Inc.

47 patents in portfolio

US11679161utility2023
Muscle Targeting Complexes and Uses Thereof for Treating Facioscapulohumeral Muscular Dystrophy
0 cites
US11672872utility2023
Anti-transferrin Receptor Antibody and Uses Thereof
0 cites
US11648318utility2023
Anti-transferrin Receptor (TFR) Antibody and Uses Thereof
0 cites
US11638761utility2023
Muscle Targeting Complexes and Uses Thereof for Treating Facioscapulohumeral Muscular Dystrophy
0 cites
US11633496utility2023
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US11633498utility2023
Muscle Targeting Complexes and Uses Thereof for Treating Myotonic Dystrophy
0 cites
US11629197utility2023
Methods of Using Muscle Targeting Complexes to Deliver an Oligonucleotide to a Subject Having Facioscapulohumeral Muscular Dystrophy or a Disease Associated with Muscle Weakness
0 cites

← PreviousPage 3 of 3